What's new in the field of prostate cancer chemoprevention?

Kanwaljit Mahal, Javier Hernandez, Joseph W. Basler, Ian M. Thompson

Research output: Contribution to journalReview articlepeer-review

2 Scopus citations

Abstract

Chemoprevention trials for several malignancies are completed, planned, or underway. Prostate cancer is one of the most common forms of cancer and understandably has received considerable recent attention as a potential target for chemoprevention. This article examines chemoprevention trials for prostate cancer, including the Prostate Cancer Prevention Trial, Selenium and Vitamin E Cancer Prevention Trial, and cyclooxygenase inhibitors in the prevention of prostate cancer.

Original languageEnglish (US)
Pages (from-to)237-242
Number of pages6
JournalCurrent Oncology Reports
Volume6
Issue number3
DOIs
StatePublished - May 2004

ASJC Scopus subject areas

  • Oncology

Fingerprint Dive into the research topics of 'What's new in the field of prostate cancer chemoprevention?'. Together they form a unique fingerprint.

Cite this